EURAMOS is the European and American Osteosarcoma Study Group. The study was founded in 2001.

This website contains information about Osteosarcoma and the current EURAMOS I Trial.

To read more about EURAMOS click here.

If you have any questions regarding the EURAMOS 1 trial or any difficulties using this website, please contact mrcctu.euramos@ucl.ac.uk

What's New?

what's new

August 2016

The EURAMOS-1 Poor responders paper has been published in The Lancet on the 26th of August 2016. This can be accessed by clicking here. A summary of the result has been published on the MRC CTU at UCL website here and summaries can be accessed for participants and patients by clicking on the respective links.


March 2016

We would like to welcome to the EURAMOS-1 team Babasola Popoola, as our new EURAMOS-1 Data Manager at the MRC CTU at UCL.  Please do not hesitate to contact Babasola with any queries on data and follow ups.

October 2015

Release of the new EURAMOS-1 Protocol (version 4.0 dated 12 February 2015).  This amendment has been approved in the UK (MREC approval on 27.04.2015 and MHRA approval on 11.08.2015). This amendment was an update of the end of trial definition to comply with current legislation.  To obtain a copy of this protocol please click here or email mrcctu.euramos@ucl.ac.uk

 July 2015

The EURAMOS-1 Good Responders paper has been published in the JCO on the 1 July 2015.  It can be accessed by clicking here

March  2015

EURAMOS-1 Registration Paper Published in Annals of Oncology

The EURAMOS-1 Registration Paper has been published in Annals of Oncology and can be accessed by clicking here

Bringing Medicine to Life

Images from the Art Project are on permanent display at the Wellcome Trust 'Medicine Now' Gallery, located on the first floor of Wellcome Collection Conference Centre, 183 Euston Road, London 

Click here to read more about the Art Project.

A project inspired by the MRC Clinical Trials Unit in collaboration with Dr Martha Perisoglou in the University College Hospital, London.


New Applicant Countries

EURAMOS I is no longer accepting applications from new countries wishing to join the trial but welcomes expressions of interest from national representatives wishing to participate in future EURAMOS collaborations. Please contact us on mrcctu.euramos@ucl.ac.uk 

In focus

Scandinavian Sarcoma Group (SSG)

The Scandinavian Sarcoma Group (SSG) comprises the Scandinavian countries (Denmark, Finland, Iceland, Norway and Sweden) with a population of about 25 million people.

Since 1979, SSG has performed three non-randomized neo-adjuvant chemotherapy trials for high-grade osteosarcoma localized to the extremities.

For further information on Our Collaborators Click here.

Our Collaborators

MRC Logo
ECT Logo
EOI Logo
COG Logo
SSG Logo